Delivery Order SPE2DB22D3301-SPE2DB25FX3UN
Award Date
10/16/24
Potential Completion Date
10/17/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The order has a ceiling value of $1,711.35 and is a firm fixed price contract with a completion date of July 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Gadavist, a pharmaceutical product, with a ceiling value of $1,062.40 and an ultimate completion date of January 21, 2025. The contract is a firm-fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 1 mmol/ml bulk vials. The contract has a ceiling value of $1,704.90 and runs through April 8, 2025. It is a firm fixed-price contract with no set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $1,704.90 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Gadavist 1 mmol/ml bulk vials, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Gadavist, a medical imaging agent, with a ceiling value of $1,201.52 and a period of performance through March 14, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,942.00, is for the procurement of Gadavist, a 10 milliliters per vial medical product, with a performance period through January 8, 2024. This contract award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Gadavist, a pharmaceutical product. The contract has a ceiling value of $22,522.21 and an ultimate completion date of September 4, 2024. It is a firm fixed price contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the Gadavist product to support the medical needs of military treatment facilities and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gadavist 1 mmol/ml bulk vials, a medical product used in healthcare applications. The contract has a firm fixed price of $1,242.58 and an ultimate completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,062.40, is for the delivery of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 24, 2025. This Delivery Order is issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 1 mmol/ml bulk vial (30ml). The contract has a total ceiling value of $1,711.35 and is structured as a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for...